Chiral Nanomaterials for Antiviral Applications, From Direct Viral Inactivation to Immune Modulation
Chirality · 2026
DOI: 10.1002/chir.70159 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chirality, 2026. Verfasst von Dan Meng und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Antiviral Agents, Nanostructures, Virus Inactivation, Viruses. Die Arbeit nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Zhejiang Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
Viral infections persistently threaten public health, and chirality offers a distinctive dimension for the design of antiviral materials. Recently, a series of advances in the use of chiral nanomaterials against viruses, which fall into two major categories. The first is direct antiviral action through chiral recognition, including viral inhibition, agglutination, inactivation, and site‐selective cleavage. The second is the modulation of antiviral immunity by chiral nanoadjuvants and nanovaccines. This minireview examines representative recent work along these two lines and discusses the scientific value of each study. Building on this analysis, we present a critical perspective on the common problems of the field. Chiral inorganic nanomaterials lack a defined molecular composition, exhibit pronounced batch‐to‐batch and within‐batch heterogeneity, and possess no metric of chiral strength beyond the ensemble‐averaged circular dichroism signal. They therefore fail the fundamental requirement of material certainty in drug development, and their prospects as antiviral drugs are unpromising. Chiral molecular material adjuvants and the chiral retrofitting of aluminum adjuvants embedded in established regulatory frameworks represent relatively feasible translational paths, whereas the more realistic outlet for chiral inorganic nanomaterials lies in active protective equipment, environmental filtration, and agricultural virus control, scenarios in which the material is far less likely to enter human circulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, Jiangsu, China.
- Key Laboratory of Organosilicon Chemistry and Material Technology, Ministry of Education, Zhejiang Key Laboratory of Organosilicon Material Technology, College of Material Chemistry and Chemical Engineering, Hangzhou No…
- Zhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
ORCID-Profile: Rui Gao
Förderung
- National Natural Science Foundation of China
- Zhejiang Provincial Natural Science Foundation of China
Zitieren
APA
Meng, D., & Gao, R. (2026). Chiral Nanomaterials for Antiviral Applications, From Direct Viral Inactivation to Immune Modulation. Chirality. https://doi.org/10.1002/chir.70159
Vancouver
Meng D, Gao R. Chiral Nanomaterials for Antiviral Applications, From Direct Viral Inactivation to Immune Modulation. Chirality. 2026. doi:10.1002/chir.70159
BibTeX
@article{Meng2026,
author = {Meng, Dan and Gao, Rui},
title = {Chiral Nanomaterials for Antiviral Applications, From Direct Viral Inactivation to Immune Modulation},
journal = {Chirality},
year = {2026},
doi = {10.1002/chir.70159}
}
EUVIMED